• Supports appetite regulation and glycemic control pathways
• Plays a role in metabolic signaling via GLP-1 and GIP receptor activity
• Supports normal energy metabolism and red blood cell formation (vitamin B12)
• Provides an amino acid involved in metabolic and cellular processes (glycine)
• Designed as part of an individualized, provider-guided treatment plan

Tirzepatide is a synthetic peptide that acts on both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor pathways, which are involved in metabolic signaling related to appetite regulation and glycemic control. These pathways have been an area of active clinical and scientific interest due to their role in energy balance and glucose metabolism.

In clinical practice, medications that act on incretin pathways are used under medical supervision as part of individualized care plans. In certain cases, licensed medical providers may determine that a compounded formulation is appropriate based on patient-specific needs, tolerability considerations, or availability constraints.

This formulation also includes glycine, a naturally occurring amino acid involved in numerous metabolic and cellular processes, and vitamin B12, a micronutrient essential for normal energy metabolism and red blood cell formation. These components have long-standing roles in human physiology and are sometimes included by providers as part of broader metabolic or nutritional strategies.

As with all compounded medications, this formulation is prepared by a licensed compounding pharmacy and prescribed only after an individualized clinical evaluation. Treatment decisions, dosing, and ongoing use are determined solely by the prescribing medical provider based on safety, appropriateness, and patient history.

Important Notice: This is a compounded medication prepared by a licensed compounding pharmacy. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. This product is prescribed by a licensed medical provider following an individualized clinical evaluation. It is not an FDA-approved commercially manufactured drug.

algorx does not manufacture, compound, or dispense medications. When prescribed by a licensed healthcare provider, this medication is compounded and dispensed by Strive Pharmacy, a state-licensed compounding pharmacy. Strive Pharmacy is responsible for the compounding, labeling, and dispensing of this formulation, and will be identified on the prescription label and medication packaging.